Valuation TAUNS Laboratories,Inc.
Stocks
197A
JP3452250008
Medical Equipment, Supplies & Distribution
|
Delayed
Japan Exchange
08:23:19 29/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 517.00 JPY | -0.96% |
|
-1.90% | +1.57% |
Company Valuation: TAUNS Laboratories,Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 41,000 | 55,086 | 55,738 | - | - |
| Change | - | 34.36% | 1.18% | - | - |
| Enterprise Value (EV) 1 | 41,114 | 60,244 | 63,732 | 64,492 | 63,517 |
| Change | - | 46.53% | 5.79% | 1.19% | -1.51% |
| P/E | 7.1x | 8.67x | 10.5x | 15.5x | 13.8x |
| PBR | 3x | 3.15x | 2.83x | 2.74x | 2.61x |
| PEG | - | 1.16x | -0.5x | -0.5x | 1.2x |
| Capitalization / Revenue | 2.22x | 2.96x | 3.78x | 2.9x | 2.67x |
| EV / Revenue | 2.23x | 3.23x | 4.32x | 3.35x | 3.04x |
| EV / EBITDA | 4.72x | 6.71x | 12.6x | 9.87x | 8.96x |
| EV / EBIT | 5.12x | 7.29x | 16.6x | 13.3x | 11.8x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | 21.75 | 28 | 35.28 | 28 | 28 |
| Rate of return | 5.3% | 5.2% | 6.76% | 5.36% | 5.36% |
| EPS 2 | 57.74 | 62.07 | 49.72 | 33.75 | 37.75 |
| Distribution rate | 37.7% | 45.1% | 71% | 83% | 74.2% |
| Net sales 1 | 18,435 | 18,628 | 14,756 | 19,252 | 20,884 |
| EBITDA 1 | 8,706 | 8,980 | 5,325 | 6,531 | 7,085 |
| EBIT 1 | 8,030 | 8,265 | 3,846 | 4,833 | 5,387 |
| Net income 1 | 5,774 | 6,315 | 5,201 | 3,593 | 4,019 |
| Net Debt 1 | 114.1 | 5,157 | 7,994 | 8,755 | 7,780 |
| Reference price 2 | 410.00 | 538.00 | 522.00 | 522.00 | 522.00 |
| Nbr of stocks (in thousands) | 100,000 | 102,391 | 106,777 | - | - |
| Announcement Date | 8/13/24 A | 8/13/25 A | 8/13/26 A | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 10.5x | 4.32x | 12.61x | 6.76% | 354M | |
| -55.02x | 17.99x | -131.35x | -.--% | 23.8B | |
| -118.12x | 17.26x | -161.33x | -.--% | 11.53B | |
| 19.52x | 2.18x | 9.2x | 1.31% | 10.67B | |
| 240.84x | 8.31x | 47.39x | -.--% | 8.97B | |
| 21.15x | 4.2x | 11.59x | - | 6.51B | |
| 21.01x | 7.27x | 16.33x | 2.74% | 5.81B | |
| 22.95x | 3.75x | 11.62x | 1.64% | 4.46B | |
| 18.02x | - | - | 3.4% | 2.9B | |
| Average | 20.09x | 8.16x | -22.99x | 1.98% | 8.33B | |
| Weighted average by Cap. | 1.54x | 11.27x | -58.75x | 0.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 197A Stock
- Valuation TAUNS Laboratories,Inc.
Select your edition
All financial news and data tailored to specific country editions
